FDA Clearance Tracker · P140033-S084
Assurity MRI, Endurity MRI family of Pacemakers
Last checked: Nov 20, 2026Latest source record: Apr 1, 2025 (this decision)Source: openFDAMethods & limitations
Decided
Apr 1, 2025
Approved
Time to decision
459 days
Received Dec 29, 2023. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P140033-S084
- Device name
- Assurity MRI, Endurity MRI family of Pacemakers
- Applicant
- ABBOTT MEDICAL
- Applicant location
- Sylmar, CA
- Received
- Dec 29, 2023
- Decided
- Apr 1, 2025
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Change Design/Components/Specifications/Material
- Original approval
- P140033
Device type
- Device class
- Class III
- Specialty
- CardiologyElectrophysiology
FDA's approval statement
As written in FDA's record.
approval for the Merlin 2 Patient Care System (PCS) Programmer MER3700 with software Model MER3400 v1.9.1 and Merlin Live Connect Software, Model MLC1000.
Source documents
Other decisions for ABBOTT MEDICAL
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
P260019 · Decided Oct 27, 2026 · 180 days after receipt
Device type: Para-device leak occluder (SJT) · Cardiology
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.